CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in CalciMedica, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +4 vs. Q2 2024
- Shares held
- 3.06M
- +100.9K (+3.4%) vs. Q2 2024
- Total value
- $13.6M
- +$1.83M (+15.6%) vs. Q2 2024
- New holders
- 6
- 5 more added
- Sold out
- 2
- 3 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CALC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $8.39M |
| Q1 2026 | 27 | $592.5K |
| Q4 2025 | 31 | $24.2M |
| Q3 2025 | 31 | $10.9M |
| Q2 2025 | 30 | $5.93M |
| Q1 2025 | 30 | $7.49M |
| Q4 2024 | 29 | $15.1M |
| Q3 2024 | 24 | $13.6M |
| Q2 2024 | 21 | $11.8M |
| Q1 2024 | 20 | $14.8M |
| Q4 2023 | 12 | $1.49M |
| Q3 2023 | 13 | $1.56M |
| Q2 2023 | 13 | $2.72M |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 27 | $5.97M |
| Q3 2022 | 25 | $10.2M |
| Q2 2022 | 25 | $11.7M |
| Q1 2022 | 27 | $13.5M |
| Q4 2021 | 28 | $20.7M |
| Q3 2021 | 27 | $37.0M |
| Q2 2021 | 41 | $63.7M |
| Q1 2021 | 51 | $72.8M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding CalciMedica, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 1,000,000 | $4.43M | 0.07% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 783,904 | $3.47M | 0.29% | 00.0% | Unchanged |
| Aisling Capital Management LP | 521,114 | $2.31M | 0.88% | 00.0% | Unchanged |
| Vanguard Group Inc | 254,148 | $1.13M | 0.00% | +1,347+0.5% | Added |
| BML Capital Management, LLC | 153,887 | $681.7K | 0.40% | −6,537−4.1% | Reduced |
| Geode Capital Management, LLC | 66,553 | $294.8K | 0.00% | +22,525+51.2% | Added |
| Millennium Management LLC | 55,233 | $244.7K | 0.00% | −6,354−10.3% | Reduced |
| Meritage Portfolio Management | 46,000 | $204.0K | 0.01% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 43,631 | $193.3K | 0.00% | +21,375+96.0% | Added |
| Atria Investments LLC | 26,503 | $117.4K | 0.00% | +15,296+136.5% | Added |
| J. Goldman & Co LP | 18,900 | $83.7K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 16,066 | $71.2K | 0.00% | +16,066 | New |
| PVG Asset Management Corp | 15,115 | $67.0K | 0.27% | +15,115 | New |
| Tritonpoint Wealth, LLC | 15,119 | $64.1K | 0.01% | 00.0% | Unchanged |
| First Manhattan Co | 13,226 | $58.6K | 0.00% | 00.0% | Unchanged |
| Cetera Investment Advisers | 12,307 | $54.5K | 0.00% | +12,307 | New |
| Bank of America Corp | 9,210 | $40.8K | 0.00% | +202+2.2% | Added |
| Connective Capital Management, LLC | 10,000 | $37.0K | 0.03% | +10,000 | New |
| Morgan Stanley | 856 | $3.79K | 0.00% | 00.0% | Unchanged |
| Brown Brothers Harriman & Co | 308 | $1.36K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 250 | $1.00K | 0.00% | +250 | New |
| Federation des caisses Desjardins du Quebec | 200 | $886 | 0.00% | +200 | New |
| JPMorgan Chase & Co | 17 | $75 | 0.00% | −1−5.6% | Reduced |
| UBS Group AG | 15 | $66 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −921−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |